Nitrobenzofuroxane derivatives as dual action HIV-1 inhibitors | Sciact

Nitrobenzofuroxane derivatives as dual action HIV-1 inhibitors Научная публикация

Журнал

Биомедицинская химия
ISSN: 2310-6905 , E-ISSN: 2310-6972

Вых. Данные

Год: 2016, Том: 62, Номер: 6, Страницы: 725-728 Страниц : 4 DOI: 10.18097/pbmc20166206725

Авторы

Korolev S.P. ¹ , Pustovarova M.A. ¹ , Starosotnikov A.M. ² , Bastrakov M.A. ² , Agapkina Yu.Yu. ¹ , Shevelev S.A. ² , Gottikh M.B. ¹

Организации

1	Belozeksky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia
2	Zelinsky Institute of Organic Chemistry, Moscow, Russia

Human immunodeficiency virus first type (HIV-1) is a main cause of one of the most dangerous diseases, AIDS. The search for new inhibitors of the virus still remains an urgent task. One approach to suppress the HIV infection is to use a double-acting inhibitors, i.e. inhibitors directed to two stages of the viral life cycle. The catalytic domain of HIV-1 integrase has a similar spatial organization with ribonuclease (RNase H) domain of HIV-1 reverse transcriptase, and approach aimed to create HIV-1 integrase and RNase H double-acting is very promising. In this work we synthesized a series of 6-nitrobenzofuroxane derivatives and studied their ability to inhibit two viral enzymes – integrase and RNase H HIV-1.

Korolev S.P. , Pustovarova M.A. , Starosotnikov A.M. , Bastrakov M.A. , Agapkina Y.Y. , Shevelev S.A. , Gottikh M.B.
Nitrobenzofuroxane derivatives as dual action HIV-1 inhibitors
Биомедицинская химия. 2016. V.62. N6. P.725-728. DOI: 10.18097/pbmc20166206725 Scopus OpenAlex

Scopus:	2-s2.0-85016122975
OpenAlex:	W2747277708

БД	Цитирований
OpenAlex	3
Scopus	3